A new, low-cost, scalable package for diagnosing tuberculosis (TB) onsite in resource-poor community settings is feasible and effective, according to a new trial.
Mar 10, 2023
0
55
The link between symptoms of COVID-19 and physical inactivity is increasingly evident. An article recently published in the journal Scientific Reports by researchers at the University of São Paulo (USP) in Brazil describes ...
Mar 8, 2023
0
98
Newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19 than the original, single-strain "ancestral" vaccines, new research by UNSW's Kirby institute published today in Nature ...
Mar 3, 2023
0
54
A new app developed by scientists at Stanford Medicine and other institutions can detect skin lesions caused by mpox, previously known as monkeypox, in images with an accuracy of 90%, the researchers found in a study. To ...
Mar 3, 2023
0
17
Babies born preterm decreased and stillborn rates remained unchanged during the first four months of COVID-19 lockdowns, according to a largescale international study.
Feb 27, 2023
0
15
Researchers said Tuesday they have identified a particularly severe form of mpox in people with advanced HIV which had a death rate of 15 percent among patients with AIDS.
Feb 21, 2023
0
88
Findings from a Johns Hopkins Children's Center study in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis. ...
Jan 27, 2023
0
32
A new study has shown the benefit of using a quick clinic-based diagnostic test for hepatitis C virus (HCV) infection over a standard laboratory-based test. The findings from the study has led to World Health Organization ...
Jan 25, 2023
0
43
High levels of stigma experienced by some COVID long-haulers are associated with more intense symptoms, reduced physical function and loss of employment due to disability, according to newly published research in eClinicalMedicine.
Jan 16, 2023
0
100
A three-dose regimen of a whole-parasite vaccine against malaria—called Plasmodium falciparum sporozoite (PfSPZ) vaccine—demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which ...
Jan 4, 2023
0
71
